Methimazole discontinuation before radioiodine therapy in patients with Graves' disease

被引:6
作者
Zakavi, Seyed R. [1 ]
Khazaei, Ghodsiye [2 ]
Sadeghi, Ramin [1 ]
Ayati, Narjess [1 ]
Davachi, Behrouz [3 ]
Bonakdaran, Shokoufeh [2 ]
Jabbari Nooghabi, Mehdi [4 ,5 ]
Moosavi, Zohreh [2 ]
机构
[1] Ghaem Hosp, Nucl Med Res Ctr, Mashhad, Iran
[2] Ghaem Hosp, Endocrine Res Ctr, Mashhad, Iran
[3] Ghaem Hosp, Dept Radiol, Mashhad, Iran
[4] Mashhad Univ Med Sci, Fac Med, Imam Reza Hosp, Surg Oncol Res Ctr, Mashhad 9176699199, Iran
[5] Ferdowsi Univ Mashhad, Fac Math Sci, Dept Stat, Mashhad, Iran
关键词
Graves' disease; hyperthryoidism; I-131; methimazole; radioiodine therapy; thyroid uptake; RADIOACTIVE IODINE; THIONAMIDE WITHDRAWAL; CURE RATE; HYPERTHYROIDISM; PROPYLTHIOURACIL; PRETREATMENT; CARBIMAZOLE; DIAGNOSIS; VOLUME;
D O I
10.1097/MNM.0000000000000384
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction Although radioiodine therapy (RIT) has been used for the treatment of hyperthyroidism for many decades, there is no consensus on the optimal time of methimazole (MMI) discontinuation before RIT. The aim of this clinical trial is to study the effect of three different time points of MMI discontinuation on response to RIT. Method and patients Overall, 151 patients (18-65 years old), with Graves' disease who were taking MMI and referred to I-131 therapy, were consecutively assigned to one of three groups, and MMI was discontinued for 24-48, 48.1-72, and 72.1-168h in group, 1, 2, and 3, respectively. Radioiodine uptake was measured in all patients and the radioiodine dose was calculated according to the Quimby formula to deliver 7.4MBq of I-131 per gram of thyroid weight. Response to RIT was assessed at 1, 3, 6, and 12 months after RIT. Results A total of 102 women and 49 men were included in the study. The mean administered dose of I-131 was 362.9188.7MBq (9.8 +/- 5.1mCi) and the mean time to response for radioiodine was 4.1 +/- 3.6 months. There was no significant difference between the three groups in age, thyroid weight, anti-TPO level, radioactive iodine uptake level, and radioiodine dose (P>0.1). Response to RIT at 1, 3, 6, and 12 months after administration was also not different between the three groups (P>0.57). Conclusion No difference was found in the response to treatment between patients with MMI discontinuation for 24-48, 48.1-72, and 72.1-96h before RIT. Shorter discontinuation of MMI before RIT may be preferable in most patients. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:1202 / 1207
页数:6
相关论文
共 32 条
[1]   Peripheral parameters of oxidative stress in Graves' disease: the effects of methimazole and 131 iodine treatments [J].
Abalovich, M ;
Llesuy, S ;
Gutierrez, S ;
Repetto, M .
CLINICAL ENDOCRINOLOGY, 2003, 59 (03) :321-327
[2]  
Aktay R, 1996, J NUCL MED, V37, P1815
[3]   Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism [J].
Andrade, VA ;
Gross, JL ;
Maia, AL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4012-4016
[4]   The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: One-year follow-up of a prospective, randomized study [J].
Andrade, VA ;
Gross, JL ;
Maia, AL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3488-3493
[5]   Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine [J].
Azizi, F ;
Ataie, L ;
Hedayati, M ;
Mehrabi, Y ;
Sheikholeslami, F .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (05) :695-701
[6]   Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists [J].
Bahn, Rebecca S. ;
Burch, Henry B. ;
Cooper, David S. ;
Garber, Jeffrey R. ;
Greenlee, M. Carol ;
Klein, Irwin ;
Laurberg, Peter ;
McDougall, I. Ross ;
Montori, Victor M. ;
Rivkees, Scott A. ;
Ross, Douglas S. ;
Sosa, Julie Ann ;
Stan, Marius N. .
THYROID, 2011, 21 (06) :593-646
[7]   Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy [J].
Bartalena, L ;
Marcocci, C ;
Bogazzi, F ;
Manetti, L ;
Tanda, ML ;
Dell'Unto, E ;
Bruno-Bossio, G ;
Nardi, M ;
Bartolomei, MP ;
Lepri, A ;
Rossi, G ;
Martino, E ;
Pinchera, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) :73-78
[8]   Graves' Ophthalmopathy [J].
Bartalena, Luigi ;
Tanda, Maria Laura .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10) :994-1001
[9]   Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease [J].
Bogazzi, F ;
Bartalena, L ;
Campomori, A ;
Brogioni, S ;
Traino, C ;
De Martino, F ;
Rossi, G ;
Lippi, F ;
Pinchera, A ;
Martino, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) :4490-4495
[10]   Propylthiouracil before 131I therapy of hyperthyroid diseases:: Effect on cure rate evaluated by a randomized clinical trial [J].
Bonnema, SJ ;
Bennedbæk, FN ;
Veje, A ;
Marving, J ;
Hegedüs, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) :4439-4444